Back to Search Start Over

Preparation of 99mTc-Clomiphene Citrate as a Novel Agent for Breast Cancer Imaging.

Authors :
Ibrahim, Ismail Taha
Elkolally, Mohamed Taha
Elgany, Ibrahim Yousof Abd
Albary, Ahmed Abd
Elsayed, Mohamed Hodhod
Source :
ISRN Oncology. 2012, p1-7. 7p.
Publication Year :
2012

Abstract

The aim of this work was to develop a novel 99mTc-labelled derivative based on triphenylethylene for breast cancer imaging. 99mTc- Clomiphene was obtained with a radiochemical yield of 94.4% by adding 99mTc to 1.5mg Clomiphene citrate in the presence of 10 μg SnCl2 at pH 7. The optimization of the labeling yield of Clomiphene citrate, with 99mTc, is described. The reaction parameters that affect the labeling yield were studied to optimize the labeling conditions. Radiochemical purity of the final product has been verified by means of paper chromatography and paper electrophoresis. Ehrlich Ascites Carcinoma (EAC) as a model of breast cancer cells was injected intraperitoneally (IP) to produce ascites and intramuscularly (IM) to produce solid tumor. Biodistribution study was carried out by the injecting solution of 99mTc-Clomiphene in normal and tumor bearing mice. The uptake in ascites was over 12.5 % injected dose per gram tissue body weight, at 1hr after injection and above 12% in solid tumor. The T/NT value for 99mTc-Clomiphene complex was found to be 5.5 ± 0.4 which was higher than that of the commercially available 99mTc-MIBI. This data revealed the localization of tracer in tumor tissue with high percent sufficient to use 99mTc-Clomiphene as a promising tool for the diagnosis of breast cancer. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20905661
Database :
Academic Search Index
Journal :
ISRN Oncology
Publication Type :
Academic Journal
Accession number :
86992420
Full Text :
https://doi.org/10.5402/2012/581281